Martin MBA - FWBI Old Senior Development
Executive
Martin MBA is Senior Development of FWBI Old
| Phone | 561 589 7020 |
| Web | https://www.firstwavebio.com |
FWBI Old Management Efficiency
The company has return on total asset (ROA) of (0.2707) % which means that it has lost $0.2707 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1528) %, meaning that it created substantial loss on money invested by shareholders. FWBI Old's management efficiency ratios could be used to measure how well FWBI Old manages its routine affairs as well as how well it operates its assets and liabilities.FWBI Old currently holds 826.84 K in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. FWBI Old has a current ratio of 0.1, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about FWBI Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| MD FACC | ZyVersa Therapeutics | 75 | |
| Dr MPH | Dermata Therapeutics | 60 | |
| Sai Iyer | LMF Acquisition Opportunities | N/A | |
| Stephen McAndrew | Sonnet Biotherapeutics Holdings | 71 | |
| Esq JD | Cardio Diagnostics Holdings | 60 | |
| Ben JD | Immix Biopharma | N/A | |
| Kimberly Davis | Zura Bio Limited | 57 | |
| Gary Whale | Zura Bio Limited | 50 | |
| David Brady | Zura Bio Limited | N/A | |
| Sandra Vedrick | Revelation Biosciences | N/A | |
| Gael Hedou | Sonnet Biotherapeutics Holdings | 53 | |
| MD FFPM | Immix Biopharma | 65 | |
| Maria MBA | Dermata Therapeutics | 74 | |
| Mark MBA | X4 Pharmaceuticals | 61 | |
| Tim Varacek | LMF Acquisition Opportunities | N/A | |
| Melda Oconnell | ZyVersa Therapeutics | N/A | |
| Verender Badial | Zura Bio Limited | 52 | |
| Tom Mullen | LMF Acquisition Opportunities | N/A | |
| Pharm MPH | X4 Pharmaceuticals | N/A | |
| Robert Arbeit | X4 Pharmaceuticals | 77 | |
| Kiran MBBS | Zura Bio Limited | 52 | |
Management Performance
| Return On Equity | -0.15 | |||
| Return On Asset | -0.27 |
FWBI Old Leadership Team
Elected by the shareholders, the FWBI Old's board of directors comprises two types of representatives: FWBI Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of FWBI. The board's role is to monitor FWBI Old's management team and ensure that shareholders' interests are well served. FWBI Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, FWBI Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| James MD, Consultant | ||
| Jack Syage, COO President | ||
| Sarah CPA, Chief Officer | ||
| Amy ChandlerSkerkis, QA Affairs | ||
| RPh MBA, CEO President | ||
| Martin MBA, Senior Development |
FWBI Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is FWBI Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.15 | |||
| Return On Asset | -0.27 | |||
| Current Valuation | 72.56 M | |||
| Shares Outstanding | 2.03 M | |||
| Shares Owned By Insiders | 5.66 % | |||
| Shares Owned By Institutions | 1.46 % | |||
| Number Of Shares Shorted | 46.6 K | |||
| Price To Book | 1.87 X | |||
| EBITDA | (15.74 M) | |||
| Net Income | (15.79 M) |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in FWBI Stock
If you are still planning to invest in FWBI Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FWBI Old's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Global Correlations Find global opportunities by holding instruments from different markets |